Tysabri and Menstruation irregular - a phase IV clinical study of FDA data

Summary:

Menstruation irregular is reported as a side effect among people who take Tysabri (natalizumab), especially for people who are 30-39 old, have been taking the drug for 2 - 5 years also take Avonex, and have Gait disturbance.

The phase IV clinical study analyzes which people have Menstruation irregular when taking Tysabri. It is created by eHealthMe based on reports of 220,870 people who have side effects when taking Tysabri from the FDA, and is updated regularly.

What is Tysabri?

Tysabri has active ingredients of natalizumab. It is often used in multiple sclerosis. eHealthMe is studying from 221,369 Tysabri users. Check the latest studies of Tysabri.

What is Menstruation irregular?

Menstruation irregular is found to be associated with 626 drugs and 911 conditions by eHealthMe. Check the latest studies of Menstruation irregular.

On Jul, 11, 2026

220,870 people reported to have side effects when taking Tysabri.
Among them, 198 people (0.09%) have Menstruation irregular.

Could Tysabri cause Menstruation irregular?

Among these 198 people:

How long have people been on Tysabri when they have Menstruation irregular? *

Click here to view more results

What is the age of people who have Menstruation irregular when taking Tysabri? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Tysabri and have Menstruation irregular?

- Check whether Menstruation irregular is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tysabri:

Tysabri (221,369 reports)

Menstruation irregular treatments and more:

Menstruation irregular (33,585 reports)

How severe was Menstruation irregular and when was it recovered:

Menstruation irregular in Tysabri

Expand to all the drugs that have ingredients of natalizumab:

Menstruation irregular and drugs with ingredients of natalizumab (236 reports)

Sub-studies by age:

0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tysabri:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Menstruation irregular:

Menstruation irregular (626 drugs)

Browse all the conditions that are associated with Menstruation irregular:

Menstruation irregular (911 conditions)

Related publications that referenced our studies

Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on natalizumab (the active ingredients of Tysabri) and Tysabri (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.